Atherosclerotic cardiovascular disease and lipid disorders are common in pa
tients with rheumatologic disorders. Plasma lipids should be screened and l
ipid disorders actively treated in an attempt to reduce cardiovascular risk
in this population. Care should be taken to avoid side effects and drug in
teractions, which may be somewhat more likely to occur in rheumatolotic pat
ients.